KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Invested Capital (2016 - 2025)

Historic Invested Capital for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Ionis Pharmaceuticals' Invested Capital rose 7666.09% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 7666.09%. This contributed to the annual value of $588.4 million for FY2024, which is 3650.27% up from last year.
  • Ionis Pharmaceuticals' Invested Capital amounted to $1.2 billion in Q3 2025, which was up 7666.09% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Invested Capital peaked at $1.3 billion during Q2 2025, and registered a low of $308.1 million during Q2 2024.
  • For the 5-year period, Ionis Pharmaceuticals' Invested Capital averaged around $624.3 million, with its median value being $592.5 million (2021).
  • In the last 5 years, Ionis Pharmaceuticals' Invested Capital crashed by 6325.15% in 2021 and then surged by 30952.94% in 2025.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Invested Capital stood at $775.3 million in 2021, then fell by 26.1% to $572.9 million in 2022, then dropped by 24.76% to $431.0 million in 2023, then soared by 36.5% to $588.4 million in 2024, then soared by 112.27% to $1.2 billion in 2025.
  • Its Invested Capital was $1.2 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $475.7 million in Q1 2025.